Agar Composition Modulates Production of Trichoderma Peptaibols, Affecting Antibacterial and Antiproliferative Activity
Language English Country United States Media electronic
Document type Journal Article
Grant support
INTER-COST LUC24099 (COST Action CA21145 EURESTOP)
Ministerstvo Školství, Mládeže a Tělovýchovy
UK/3211/2024
Univerzita Komenského v Bratislave
VEGA 1/0388/22
Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
APVV-19-0094
Agentúra na Podporu Výskumu a Vývoja
PubMed
40540086
PubMed Central
PMC12181216
DOI
10.1007/s00284-025-04322-x
PII: 10.1007/s00284-025-04322-x
Knihovny.cz E-resources
- MeSH
- Agar * chemistry MeSH
- Anti-Bacterial Agents * pharmacology metabolism MeSH
- Hypocreales MeSH
- Culture Media chemistry MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Cell Line, Tumor MeSH
- Peptaibols * pharmacology metabolism biosynthesis chemistry MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents * pharmacology metabolism MeSH
- Pseudomonas aeruginosa drug effects MeSH
- Staphylococcus aureus drug effects MeSH
- Trichoderma * metabolism growth & development chemistry MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Agar * MeSH
- Anti-Bacterial Agents * MeSH
- Culture Media MeSH
- Peptaibols * MeSH
- Antineoplastic Agents * MeSH
Current antibiotics and chemotherapeutics are becoming ineffective because pathogenic bacteria and tumor cells have developed multiple drug resistance. Therefore, it is necessary to find new substances that can be used in treatment, either alone or as sensitizing molecules in combination with existing drugs. Peptaibols are bioactive, membrane-active peptides of non-ribosomal origin, mainly produced by filamentous fungi such as Trichoderma spp. This study focused on producing peptaibol-rich extracts from Trichoderma atroviride O1, cultivated on malt extract agar (MA) under circadian and constant darkness conditions for 13 days. Peptaibol production was detected by MALDI-TOF mass spectrometry after six days of cultivation. The extracts demonstrated antibacterial activity against Staphylococcus aureus strains, particularly the methicillin-resistant variant, but not against the Gram-negative Pseudomonas aeruginosa. Quorum sensing interference revealed that a peptaibol-rich extract suppressed Vibrio campbellii BAA-1119's AI-2 signaling system to a degree comparable with gentamycin. Beyond antibacterial properties, the extracts exhibited notable antiproliferative activity against human ovarian cancer cells and their adriamycin-resistant subline in both 2D and 3D models. Specifically, MA-derived extracts reduced ovarian cancer cell viability by 70% at 50 μg/mL, especially under light/dark regime of cultivation. Compared to previously published results for PDA-based extracts, MA cultivation shifted the biological effects of peptaibol-containing extracts toward anticancer potential. These findings support the idea that modifying fungal cultivation parameters, the bioactivity of secondary metabolite mixtures can be tailored for specific therapeutic applications.
See more in PubMed
Ramos A, Sadeghi S, Tabatabaeian H (2021) Battling chemoresistance in cancer: root causes and strategies to uproot them. Int J Mol Sci 22(17):9451. 10.3390/ijms22179451 PubMed PMC
Yang FC, Wang C, Zhu J, Gai QJ, Mao M, He J, Qin Y, Yao XX, Wang YX, Lu HM, Cao MF, He MM, Wen XM, Leng P, Cai XW, Yao XH, Bian XW, Wang Y (2022) Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain. Am J Cancer Res 13(11):5174–5196 PubMed
Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H (2023) Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 10.1016/j.drup.2022.100916 PubMed
Smith L, Watson MB, O’Kane SL, Drew PJ, Lind MJ, Cawkwell L (2006) The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol Cancer Ther 5:2115–2120 PubMed
Sosa Iglesias V, Giuranno L, Dubois LJ, Theys J, Vooijs M (2018) Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting? Front Oncol 8:267. 10.3389/fonc.2018.00267 PubMed PMC
Murray S, Briasoulis E, Linardou H, Bafaloukos D, Papadimitriou C (2012) Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies. Cancer Treat Rev 38:890–903. 10.1016/j.ctrv.2012.02.011 PubMed
Huang W-C, Kuo K-T, Wang C-H, Yeh C-T, Wang Y (2019) Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway. J Exp Clin Cancer Res 38:1–17. 10.1186/s13046-019-1166-3 PubMed PMC
Vulsteke C, Pfeil AM, Schwenkglenks M, Pettengell R, Szucs TD, Lambrechts D, Peeters M, van Dam P, Dieudonné A-S, Hatse S (2014) Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Res Treat 147:557–570. 10.1007/s10549-014-3105-5 PubMed
Wang B, Ma N, Zheng X, Li X, Ma X, Hu J, Cao B (2020) GDF15 repression contributes to 5-fluorouracil resistance in human colon cancer by regulating epithelial-mesenchymal transition and apoptosis. BioMed Res Int 2020:2826010 PubMed PMC
Sládek NE, Kollander R, Sreerama L, Kiang DT (2002) Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Cancer Chemother Pharmacol 49:309–321. 10.1007/s00280-001-0412-4 PubMed
Wang X, Xu Z, Sun J, Lv H, Wang Y, Ni Y, Chen S, Hu C, Wang L, Chen W (2020) Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transition. J Cell Mol Med 24:3625–3633. 10.1111/jcmm.15055 PubMed PMC
Mora-Lagos B, Cartas-Espinel I, Riquelme I, Parker AC, Piccolo SR, Viscarra T, Reyes ME, Zanella L, Buchegger K, Ili C (2020) Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines. PLoS ONE 15:e0228331. 10.1371/journal.pone.0228331 PubMed PMC
Ballestreri É, Simon D, de Souza AP, Grott CS, Nabinger DD, Dihl RR, Grivicich I (2018) Resistance mechanism to cisplatin in NCI-H460 non-small cell lung cancer cell line: investigating apoptosis, autophagy, and cytogenetic damage. Cancer Drug Resist 1:72–81. 10.20517/cdr.2017.02
Ru Y, Chen XJ, Guo WZ, Gao SG, Qi YJ, Chen P, Feng XS, Zhang SJ (2018) Neat1_2–sFPQ axis mediates cisplatin resistance in liver cancer cells in vitro. Onco Targets Ther 11:5695. 10.2147/OTT.S163774 PubMed PMC
Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G (2014) Systems biology of cisplatin resistance: past, present and future. Cell Death Dis 5:e1257. 10.1038/cddis.2013.428 PubMed PMC
Liu X, Pan CG, Luo ZQ (2019) High expression of NFAT2 contributes to carboplatin resistance in lung cancer. Exp Mol Pathol 110:104290. 10.1016/j.yexmp.2019.104290 PubMed
Hu Y, Su Y, Lei X, Zhao H, Wang L, Xu T, Guo J, Yang W, Zhang X (2020) LINC00641/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma. Sci Rep 10:1–11. 10.1038/s41598-020-70913-2 PubMed PMC
Lin Q, Luo L, Wang H (2021) A new oxaliplatin resistance-related gene signature with strong predicting ability in colon cancer identified by comprehensive profiling. Front Oncol 11:644956. 10.3389/fonc.2021.644956 PubMed PMC
Zhang X, Xu P, Ni W, Fan H, Xu J (2016) Downregulated DYRK2 expression is associated with poor prognosis and oxaliplatin resistance in hepatocellular carcinoma. Pathol Res Pract 212(3):162–170. 10.1016/j.prp.2016.01.002 PubMed
Li X, Yao R, Yue L, Qiu W, Qi W, Liu S, Yao Y, Liang J (2014) FOXM 1 mediates resistance to docetaxel in gastric cancer via up-regulating stathmin. J Cell Mol Med 18:811–823. 10.1111/jcmm.12216 PubMed PMC
Nielsen DL, Palshof JA, Brünner N, Stenvang J, Viuff BM (2017) Implications of ABCG2 expression on irinotecan treatment of colorectal cancer patients: a review. Int J Mol Sci 18:1926. 10.3390/ijms18091926 PubMed PMC
Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B (2017) The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 7:339. 10.15171/apb.2017.041 PubMed PMC
Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT et al (2020) The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368(6494):973–980. 10.1126/science.aay9189 PubMed PMC
Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399(10325):629–655. 10.1016/S0140-6736(21)02724-0 PubMed PMC
Guo H, Tong Y, Cheng J, Abbas Z, Li Z, Wang J, Zhou Y, Si D, Zhang R (2022) Biofilm and small colony variants—an update on staphylococcus aureus strategies toward drug resistance. Int J Mol Sci 23(3):1241 PubMed PMC
Castro GS, Sousa TF, da Silva DF, Pedroso RCN, Menezers KS, Soares MA, Dias GM, Santos AO, Yamagishi MEB, Faria JV, Jonuário AH, Koolen HHF (2023) Characterization of peptaibols produced by a marine strain of the fungus trichoderma endophyticum via mass spectrometry, genome mining and phylogeny-based prediction. Metabolites. 10.3390/metabo13020221 PubMed PMC
Daniel SJF, Filho ER (2007) Peptaibols of PubMed
Víglaš J, Dobiasova S, Viktorova J, Ruml T, Repiska V, Olejnikova P et al (2021) Peptaibol-containing extracts of PubMed PMC
Hou X, Sun R, Feng Y, Zhang R, Zhu T, Che Q, Zhang G, Li D (2022) Peptaibols: diversity, bioactivity, and biosynthesis. Eng Microbiol 2(3):100026. 10.1016/j.engmic.2022.100026 PubMed PMC
Tang P, Huang D, Zheng KX, Hu D, Dai P, Li CH, Qin SY, Chen GD, Yao XS, Gao H (2023) Thirteen new peptaibols with antimicrobial activities from PubMed
Kuvarina AE, Sukonnikov MA, Timofeeva AV, Serebryakova MV, Baratova LA, Buzurnyuk MN, Golyshkin AV, Georgieva ML, Sadykova VS (2023) Uncovering the effects of the cultivation condition on different forms of peptaibol’s emericellipsins production from an alkaliphilic fungus.
Gajdács M, Spengler G, Sanmartín C, Marć MA, Handzlik J, Domínguez-Álvarez E (2017) Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: a confirmation study in a colon cancer MDR cell line. Bioorg Med Chem Lett 27:797–802. 10.1016/j.bmcl.2017.01.033 PubMed
Viktorová J, Kumar R, Řehořová K, Hoang L, Ruml T, Figueroa CR, Valdenegro M, Fuentes L (2020) Antimicrobial activity of extracts of two native fruits of Chile: arrayan ( PubMed PMC
Evidente A (2024) Advances on anticancer fungal metabolites: sources, chemical and biological activities in the last decade (2012–2023). Nat Prod Bioprospect 14:31. 10.1007/s13659-024-00452-0 PubMed PMC
Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335 PubMed PMC
Vandermolen KM, Raja HA, El-Elimat T, Oberlies NH (2013) Evaluation of culture media for the production of secondary metabolites in a natural products screening program. AMB Express 3(1):71. 10.1186/2191-0855-3-71 PubMed PMC
Komon-Zelazowska M, Neuhof T, Dieckmann R, von Döhren H, Herrera-Estrella A, Kubicek CP, Druzhinina IS (2007) Formation of atroviridin by hypocrea atroviridis is conidiation associated and positively regulated by blue light and the G protein GNA3. Eukaryot Cell. 10.1128/ec.00143-07 PubMed PMC
Alfaro-Vargas P, Bastos-Salas A, Muñoz-Arrieta R, Pereira-Reyes R, Redondo-Solano M, Fernández J, Mora-Villalobos A, López-Gómez JP (2022) Peptaibol production and characterization from PubMed PMC
Chaicharoenaudomrung N, Kunhorm P, Noisa P (2019) Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling. World J Stem Cells 11:1065–1083. 10.4252/wjsc.v11.i12.1065 PubMed PMC
Casagrande N, Borghese C, Gabbatore L, Morbiato L, De Zotti M, Aldinucci D (2021) Analogs of a natural peptaibol exert anticancer activity in both cisplatin- and doxorubicin-resistant cells and in multicellular tumor spheroids. Int J Mol Sci 22(16):8362. 10.3390/ijms22168362 PubMed PMC
Buri MV, Torquato HFV, Barros CC, Ide JS, Miranda A, Paredes-Gamero EJ (2017) Comparison of cytotoxic activity in leukemic lineages reveals important features of β-hairpin antimicrobial peptides. J Cell Biochem 118(7):1764–1773. 10.1002/jcb.25844 PubMed
Leitgeb B, Szekeres A, Manczinger L, Vágvölgyi C, Kredics L (2007) The history of alamethicin: a review of the most extensively studied peptaibol. Chem Biodivers 4(6):1027–1051. 10.1002/cbdv.200790095 PubMed
Yong YC, Zhong JJ (2013) Impacts of quorum sensing on microbial metabolism and human health. Adv Biochem Eng Biotechnol 131:25–61. 10.1007/10_2012_138 PubMed
Szemerédi N, Kincses A, Rehorova K, Hoang L, Salardón-Jiménez N, Sevilla-Hernández C, Viktorová J, Domínguez-Álvarez E, Spengler G (2020) Ketone- and cyano-selenoesters to overcome efflux pump, quorum-sensing, and biofilm-mediated resistance. Antibiotics 9(12):896. 10.3390/antibiotics9120896 PubMed PMC
Peña-Morán OA, Villarreal ML, Alvarez L, Meneses-Acosta A, Rodríguez-López V (2016) Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from PubMed PMC
Shi M, Wang H-N, Xie S-T, Luo Y, Sun C-Y, Chen X-L, Zhang Y-Z (2010) Antimicrobial peptaibols, novel suppressors of tumor cells, targeted calcium-mediated apoptosis and autophagy in human hepatocellular carcinoma cells. Mol Cancer 9:26 PubMed PMC
Rivera-Chávez J, Raja HA, Graf TN, Gallagher JM, Metri P, Xue D, Pearce CJ, Oberlies NH (2017) Prealamethicin F50 and related peptaibols from PubMed PMC
Kavianinia I, Stubbing LA, Abbattista MR, Harris PW, Smaill JB, Patterson AV, Brimble MA (2020) Alanine scan-guided synthesis and biological evaluation of analogues of culicinin D, a potent anticancer peptaibol. Bioorganic Med Chem Lett 30:127135 PubMed
Víglaš J, Olejníková P (2019) Trichoderma atroviride: an isolate from forest environment with secondary metabolites with high antimicrobial potential. Acta Chim Slovaca 12:46–55. 10.2478/acs-2019-0008